13F HOLDINGS REPORT
Blue Owl Capital Holdings LP
Quarter ended Q2 2024 · Filed August 15, 2024 · Accession 0000950123-24-008845
Total Value
$359.6M
Positions
43
Other Managers
6
Confidential Omitted
No
Holdings (43)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | CULLINAN THERAPEUTICS INC | CGEM | 2,049,172 | $35.7M | 9.94% |
| 2 | PLIANT THERAPEUTICS INC | PLRX | 3,004,199 | $32.3M | 8.98% |
| 3 | BLUE OWL CAPITAL CORPORATION | OWL | 2,045,070 | $31.4M | 8.74% |
| 4 | KLAVIYO INC | KVYO | 1,198,270 | $29.8M | 8.29% |
| 5 | LARIMAR THERAPEUTICS INC | LRMR | 3,859,468 | $28.0M | 7.78% |
| 6 | ENGENE HOLDINGS INC | ENGNW | 2,449,827 | $23.1M | 6.43% |
| 7 | TOURMALINE BIO INC | 89157D105 | 1,715,401 | $22.1M | 6.14% |
| 8 | EVERCOMMERCE INC | EVCM | 1,641,929 | $18.0M | 5.01% |
| 9 | ACELYRIN INC | 00445A100 | 2,926,028 | $12.9M | 3.59% |
| 10 | REPARE THERAPEUTICS INC | 760273102 | 3,372,499 | $11.1M | 3.10% |
| 11 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 268,238 | $11.0M | 3.07% |
| 12 | CONTEXT THERAPEUTICS INC | CNTX | 5,161,290 | $10.3M | 2.88% |
| 13 | DISC MEDICINE INC | IRON | 215,260 | $9.7M | 2.70% |
| 14 | TOAST INC | TOST | 322,578 | $8.3M | 2.31% |
| 15 | E2OPEN PARENT HOLDINGS INC | 29788T103 | 1,650,943 | $7.4M | 2.06% |
| 16 | KEROS THERAPEUTICS INC | KROS | 157,633 | $7.2M | 2.00% |
| 17 | IKENA ONCOLOGY INC | 45175G108 | 4,091,118 | $6.8M | 1.88% |
| 18 | SAGIMET BIOSCIENCES INC | SGMT | 1,673,877 | $5.7M | 1.59% |
| 19 | MINERALYS THERAPEUTICS INC | MLYS | 450,339 | $5.3M | 1.47% |
| 20 | VIKING THERAPEUTICS INC | VKTX | 95,000 | $5.0M | 1.40% |
| 21 | INOZYME PHARMA INC | 45790W108 | 1,120,027 | $5.0M | 1.39% |
| 22 | STARWOOD PROPERTY TRUST | STHO | 226,456 | $4.3M | 1.19% |
| 23 | PYXIS ONCOLOGY INC | PYXS | 1,046,025 | $3.5M | 0.96% |
| 24 | MEREO BIOPHARMA GROUP PLC | MREO | 897,809 | $3.2M | 0.90% |
| 25 | AQUESTIVE THERAPEUTICS INC | AQST | 1,140,000 | $3.0M | 0.82% |
| 26 | COMPASS THERAPEUTICS INC | CMPX | 2,829,712 | $2.8M | 0.79% |
| 27 | ADC THERAPEUTICS SA | ADCT | 733,568 | $2.3M | 0.64% |
| 28 | OMEGA THERAPEUTICS INC | 68217N105 | 1,055,882 | $2.2M | 0.61% |
| 29 | STRUCTURE THERAPEUTICS INC | GPCR | 55,000 | $2.2M | 0.60% |
| 30 | IMMUNOVANT INC | IMVT | 80,000 | $2.1M | 0.59% |
| 31 | SYROS PHARMACEUTICALS INC | 87184Q206 | 340,855 | $1.8M | 0.49% |
| 32 | JANUX THERAPEUTICS INC | JANX | 40,000 | $1.7M | 0.47% |
| 33 | CELCUITY INC | CELC | 65,000 | $1.1M | 0.30% |
| 34 | GOHEALTH INC | GOCO | 83,264 | $814,631 | 0.23% |
| 35 | ENGENE HOLDINGS INC | ENGNW | 51,177 | $608,301 | 0.17% |
| 36 | BLEND LABS INC | BLND | 216,953 | $512,011 | 0.14% |
| 37 | PLUM ACQUISITION CORP III | G63290129 | 70,000 | $324,001 | 0.09% |
| 38 | DESKTOP METAL INC | 25058X303 | 750,000 | $309,750 | 0.09% |
| 39 | PRECISION BIOSCIENCES INC | DTIL | 20,220 | $196,741 | 0.05% |
| 40 | BLEND LABS INC | BLND | 72,317 | $170,670 | 0.05% |
| 41 | BLEND LABS INC | BLND | 72,317 | $170,670 | 0.05% |
| 42 | GERON CORPORATION | GERN | 23,918 | $101,412 | 0.03% |
| 43 | PLUM ACQUISITION CORP III | PLMWF | 666,666 | $46,667 | 0.01% |